CDK inhibitor Lerociclib dihydrochloride, Purity ≥98%

Cat. No.: X24-05-ZQ826

CDK inhibitor Lerociclib dihydrochloride, Purity ≥98%

Synonym: 2097938-59-3; G1T38 dihydrochloride; G1T 38; G1T-38; CDK inhibitor

  • CAS Number: 2097938-59-3
  • Compound CID: 129896913
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Lerociclib dihydrochloride is an CDK kinase inhibitor that disrupts cell division processes. It targets CDK1/cyclinB1, cdk2/cyclin A, CDK2/cyclinE, and Cdk4/cyclin D1.
Molecular Weight
547.52
Molecular Formula
C26H36Cl2N8O
Targets
CDK1/cyclinB1: 2.4 μM; cdk2/cyclin A: 1.5 μM; CDK2/cyclinE: 3.6 μM; Cdk4/cyclin D1: 1 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Lerociclib dihydrochloride can be used to investigate its effects as a selective CDK4/6 inhibitor in cell cycle control.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.